Strategies for continuous evaluation of the benefit–risk profile of HPV-16/18-AS04-adjuvanted vaccine-Reference-Cited by-同舟云学术

Strategies for continuous evaluation of the benefit–risk profile of HPV-16/18-AS04-adjuvanted vaccine

Published:2014-09-14 Issue:11 Volume:13 Page:1297-1306
ISSN:1476-0584
Container-title:Expert Review of Vaccines
language:en
Short-container-title:Expert Review of Vaccines

Author:

Angelo Maria-Genalin,Taylor Sylvia,Struyf Frank,Tavares Da Silva Fernanda,Arellano Felix,David Marie-Pierre,Dubin Gary,Rosillon Dominique,Baril Laurence

Publisher

Informa UK Limited

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Immunology

Link

http://www.tandfonline.com/doi/pdf/10.1586/14760584.2014.959931

Reference43 articles.

1. Vaccine effects and impact of vaccination programmes in post-licensure studies

2. Approaches to monitoring biological outcomes for HPV vaccination: Challenges of early adopter countries

3. Evaluating the impact of human papillomavirus vaccines

4. Declining Genital Warts in Young Women in England Associated With HPV 16/18 Vaccination: An Ecological Study

5. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnitude and breadth of antibody cross-reactivity induced by recombinant influenza hemagglutinin trimer vaccine is enhanced by combination adjuvants;Scientific Reports;2022-06-02

2. Administration of Multivalent Influenza Virus Recombinant Hemagglutinin Vaccine in Combination-Adjuvant Elicits Broad Reactivity Beyond the Vaccine Components;Frontiers in Immunology;2021-07-14

3. Key steps in vaccine development;Annals of Allergy, Asthma & Immunology;2020-07

4. Reply to Poddighe;The Journal of Infectious Diseases;2017-09-06

5. The safety of Cervarix? – Authors' reply;The Lancet Infectious Diseases;2017-01